Fingerprint
Dive into the research topics of 'Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically